Comparative quality control study of different brands of telmisartan tablets marketed in Andhra Pradesh, India by in-vitro testing
Article InformationTelmisartan is indicated for treating patients with high blood pressure (Hypertension).This study attempted to investigate the In-vitro quality control testing of six prominent pharmaceutical brands of telmisartan tablets marketed in Andhra Pradesh, India.Six different brands of tablets used in the study, named brand A (Telismart 40 mg), brand B (Telmisafe TM-40 mg), brand C (Teltan-40 mg), brand D (Telkonol-40 mg), brand E (telmiwock-40 mg), and brand F (Telmikind-40), were evaluated for weight variation, content uniformity, thickness, disintegration, hardness, friability, and assay.The study utilised standardised testing methods to ensure consistency and reliability across all assessments.The results revealed that all the brands of telmisartan tablets complied with the official specifications for hardness, friability, disintegration, and assay.All the selected brands of telmisartan tablets demonstrated robust mechanical strength, minimal friability, and prompt disintegration of active pharmaceutical ingredients.
Authors
- Srinivasa Babu Puttagunta (ORCID: https://orcid.org/0000-0002-4273-004X)
- Pusuluri Siva Krishna (ORCID: https://orcid.org/0000-0002-7475-4556)
- Giddaluri Ramya Sri
- C.S. Sujith Kumar
- Anitha Durairaj
- P. Navya
- M. D. Hussain
- M. M. Eswarudu (ORCID: https://orcid.org/0000-0002-2685-4739)
Publication Details
- Journal
- Journal of Pharmacy and Allied Medicine
- Published
- 2025-02-28
- DOI
- https://doi.org/10.58985/jpam.2025.v03i01.29
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00